ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 1580

HLA-B27/ Human β2-Microglobulin (β2m) Transgenic Drosophila Expresses Specific Cross-Vein Less (CVL) and Small-Eye Phenotypes Resulting from Disruption of the BMP/TGFβ Signaling Pathway

Benjamin Grandon1, Nadège Jah2, Aurore Rincheval-Arnold3, Isabelle Guénal3, Sébastien Gaumer3, Claudine Andre2, Maxime Breban4 and Gilles Chiocchia5, 1Inserm UMR 1173 and LGBC, 78180 Saint Quentin en Yvelines, France, 2Infection and inflammation, INSERM UMR1173, Montigny-le-Bretonneux, France, 3Laboratory of Genetic and Cellular Biology, Faculty of Health Sciences Simone Veil, Montigny-le-Bretonneux,, 78180 SAINT QUENTIN EN YVELINES, France, 4Rheumatology, Ambroise Paré Hospital (AP-HP), Versailles Saint Quentin en Yvelines University, INSERM UMR1173, Boulogne-Billancourt, France, 5Service d'Immunologie, Ambroise Paré Hospital, University of Versailles Saint-Quentin-en-Yvelines, Boulogne, France, Boulogne-Billancourt, France

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: human leukocyte antigens (HLA) and spondylarthropathy

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 6, 2017

Session Title: Spondyloarthropathies and Psoriatic Arthritis – Pathogenesis, Etiology Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: The association between HLA-B27 and spondyloarthritis (SpA) remains unexplained more than 40 years after its discovery. To further explore the pathogenic role of HLA-B27, we produced transgenic Drosophila for several human HLA-B alleles, associated (B*2705, B*2704) or not (B*0702) with SpA, and for the b2m invariant chain partner.

Methods: Transgenes were expressed with different drivers in the wing or eye imaginal discs (i.e. the precursor tissues of the adult fly wing or eye). Their expression was examined by PCR and Western-blot. Cell surface or intra-cellular levels of unfolded (HC10 antibody) and well-folded (ME1 and W6/32 antibodies) HLA-B were examined by FACS and by immunofluorescence (IF). Genetic interactions with candidate genes controlling several signaling pathways were addressed.

Results: IF experiments revealed high levels of well-folded HLA-B27 alleles on the cell surface, but less of the HLA-B*0702. FACS analysis confirmed that HLA-B*2705/b2m and HLA-B*2704/b2m better fold than HLA-B0702/ b2m, in Drosophila. Co-expression of HLA-B27 (B2705 or B2704) alleles and b2m in the wing tissue specifically induced the loss of posterior and anterior cross-veins leading to a CVL phenotype. Furthermore, the eye size was reduced when HLA-B27 alleles (but not HLA-B*0702) were expressed in this tissue with b2m. Genetic interaction tests for candidate signaling pathways involved in the eye and wing development showed a selective decrease of the Bone Morphogenetic Protein (BMP) signaling when HLA–B*2705/b2m was expressed with no evidence for ER stress induction. Those results were confirmed by the decreased phosphorylation of the transcription factor MAD. Altogether, our results allow us to hypothesize that HLA-B*2705 could act downstream of the BMP receptor. Moreover, overexpression of the Drosophila SMAD7 homolog Dad, a negative regulator of the BMP pathway, was observed. Interestingly, transcriptomic study showed that SpA-prone HLA-B27/b2m transgenic rat lines also exhibit a specific increase of SMAD7 in their dendritic cells.

Conclusion: HLA-B27 seems to have a better capacity to fold and reach the cell surface than HLA-B*0702, in the presence of b2m in Drosophila, even in the absence of the class-I MHC peptide-loading complex machinery . CVL and small-eye phenotypes resulting from the expression of both SpA-associated HLA-B27 subtypes (i.e. B*2705 and B*2704) but not of HLA-B*0702 was induced by disrupting MAD phosphorylation. Those results highlight the effectors (rSMADs) and inhibitor (SMAD7) of the BMP/TGFb pathway as candidate targets for the pathogenic role of HLA-B27 in SpA.


Disclosure: B. Grandon, None; N. Jah, None; A. Rincheval-Arnold, None; I. Guénal, None; S. Gaumer, None; C. Andre, None; M. Breban, None; G. Chiocchia, None.

To cite this abstract in AMA style:

Grandon B, Jah N, Rincheval-Arnold A, Guénal I, Gaumer S, Andre C, Breban M, Chiocchia G. HLA-B27/ Human β2-Microglobulin (β2m) Transgenic Drosophila Expresses Specific Cross-Vein Less (CVL) and Small-Eye Phenotypes Resulting from Disruption of the BMP/TGFβ Signaling Pathway [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/hla-b27-human-%ce%b22-microglobulin-%ce%b22m-transgenic-drosophila-expresses-specific-cross-vein-less-cvl-and-small-eye-phenotypes-resulting-from-disruption-of-the-bmptgf%ce%b2-signaling-pathway/. Accessed February 3, 2023.
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/hla-b27-human-%ce%b22-microglobulin-%ce%b22m-transgenic-drosophila-expresses-specific-cross-vein-less-cvl-and-small-eye-phenotypes-resulting-from-disruption-of-the-bmptgf%ce%b2-signaling-pathway/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences